Abstract
Breast cancer patients’ perceived risk of recurrence has been associated with psychological distress. Little is known about the change of patients’ perceived risk of recurrence over time and factors associated with their recurrence-risk perceptions. We prospectively recruited 549 newly diagnosed early-stage breast cancer patients; patients completed interviews at 6 weeks, 6 months, 1 year, and 2 years after definitive surgical treatment. A random-effects regression model with repeated ordinal measurements was used to estimate the relationship between perceived risk of recurrence and demographic, medical, and psychosocial factors. We analyzed data from 535 patients [34% ductal carcinoma in situ (DCIS); 20% non-white] who reported their perceived risk at one or more interviews. At the first interview, 16% reported having no lifetime risk of recurrence, and another 16% reported ≥50% risk of recurrence, including 15% of DCIS patients. Patients who were white (OR = 5.88, 95% CI 3.39–10.19) and had greater state anxiety (OR = 1.04, 95% CI 1.02–1.07) were more likely, while patients who received radiotherapy (OR = 0.72, 95% CI 0.54–0.96) and had more social support (OR = 0.59, 95% CI 0.46–0.75) were less likely to report higher risk of recurrence. Cancer stage was not significantly associated with perceived risk of recurrence. Perceived risk of recurrence did not change significantly over time. Educating early-stage breast cancer patients about their actual risk could result in more realistic recurrence-risk perceptions, and increasing social support could help alleviate anxiety associated with exaggerated risk perceptions.
Similar content being viewed by others
References
Bijker N, Peterse JL, Duchateau L, Julien JP, Fentiman IS, Duval C, Di Palma S, Simony-Lafontaine J, de Mascarel I, van de Vijver MJ (2001) Risk factors for recurrence and metastasis after breast-conserving therapy for ductal carcinoma-in situ: analysis of European Organization for Research and Treatment of Cancer Trial 10853. J Clin Oncol 19:2263–2271
Fisher B, Costantino J, Redmond C, Fisher E, Margolese R, Dimitrov N, Wolmark N, Wickerham DL, Deutsch M, Ore L et al (1993) Lumpectomy compared with lumpectomy and radiation therapy for the treatment of intraductal breast cancer. N Engl J Med 328:1581–1586
Habel LA, Daling JR, Newcomb PA, Self SG, Porter PL, Stanford JL, Seidel K, Weiss NS (1998) Risk of recurrence after ductal carcinoma in situ of the breast. Cancer Epidemiol Biomarkers Prev 7:689–696
Morrow M, Strom EA, Bassett LW, Dershaw DD, Fowble B, Harris JR, O’Malley F, Schnitt SJ, Singletary SE, Winchester DP (2002) Standard for the management of ductal carcinoma in situ of the breast (DCIS). CA Cancer J Clin 52:256–276
Silverstein MJ, Barth A, Poller DN, Gierson ED, Colburn WJ, Waisman JR, Gamagami P (1995) Ten-year results comparing mastectomy to excision and radiation therapy for ductal carcinoma in situ of the breast. Eur J Cancer 31A:1425–1427
Early Breast Cancer Trialists’ Collaborative Group (EBCTCG) (2005) Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 365:1687–1717
Rothrock NE, Matthews AK, Sellergren SA, Fleming G, List M (2004) State anxiety and cancer-specific anxiety in survivors of breast cancer. J Psychosoc Oncol 22:93–109
Partridge A, Adloff K, Blood E, Dees EC, Kaelin C, Golshan M, Ligibel J, de Moor JS, Weeks J, Emmons K, Winer E (2008) Risk perceptions and psychosocial outcomes of women with ductal carcinoma in situ: longitudinal results from a cohort study. J Natl Cancer Inst 100:243–251
Moser RP, McCaul K, Peters E, Nelson W, Marcus SE (2007) Associations of perceived risk and worry with cancer health-protective actions: data from the Health Information National Trends Survey (HINTS). J Health Psychol 12:53–65
Rosenstock IM, Irwin M (1990) The Health Belief Model: explaining health behavior through expectancies. In: Glanz K, Lewis FM, Rimer BK (eds) Health behavior and health education: theory, research, and practice. Jossey-Bassm, San Francisco, pp 39–62
Calvocoressi L, Kasl SV, Lee CH, Stolar M, Claus EB, Jones BA (2004) A prospective study of perceived susceptibility to breast cancer and nonadherence to mammography screening guidelines in African American and White women ages 40 to 79 years. Cancer Epidemiol Biomarkers Prev 13:2096–2105
Brain K, Norman P, Gray J, Mansel R (1999) Anxiety and adherence to breast self-examination in women with a family history of breast cancer. Psychosom Med 61:181–187
Rakovitch E, Franssen E, Kim J, Ackerman I, Pignol JP, Paszat L, Pritchard KI, Ho C, Redelmeier DA (2003) A comparison of risk perception and psychological morbidity in women with ductal carcinoma in situ and early invasive breast cancer. Breast Cancer Res Treat 77:285–293
van Gestel YR, Voogd AC, Vingerhoets AJ, Mols F, Nieuwenhuijzen GA, van Driel OJ, van Berlo CL, van de Poll-Franse LV (2006) A comparison of quality of life, disease impact and risk perception in women with invasive breast cancer and ductal carcinoma in situ. Eur J Cancer 43:549–556
Kemeny MM, Wellisch DK, Schain WS (1988) Psychosocial outcome in a randomized surgical trial for treatment of primary breast cancer. Cancer 62:1231–1237
Schover LR, Yetman RJ, Tuason LJ, Meisler E, Esselstyn CB, Hermann RE, Grundfest-Broniatowski S, Dowden RV (1995) Partial mastectomy and breast reconstruction. A comparison of their effects on psychosocial adjustment, body image, and sexuality. Cancer 75:54–64
Wade TD, Nehmy T, Koczwara B (2005) Predicting worries about health after breast cancer surgery. Psychooncology 14:503–509
Bowen D, Hickman KM, Powers D (1997) Importance of psychological variables in understanding risk perceptions and breast cancer screening of African American women. Womens Health 3:227–242
Davis S, Stewart S, Bloom J (2004) Increasing the accuracy of perceived breast cancer risk: results from a randomized trial with Cancer Information Service callers. Prev Med 39:64–73
Hughes C, Lerman C, Lustbader E (1996) Ethnic differences in risk perception among women at increased risk for breast cancer. Breast Cancer Res Treat 40:25–35
Courtens AM, Stevens FC, Crebolder HF, Philipsen H (1996) Longitudinal study on quality of life and social support in cancer patients. Cancer Nurs 19:162–169
Reynolds P, Boyd PT, Blacklow RS, Jackson JS, Greenberg RS, Austin DF, Chen VW, Edwards BK (1994) The relationship between social ties and survival among black and white breast cancer patients. National Cancer Institute Black/White Cancer Survival Study Group. Cancer Epidemiol Biomarkers Prev 3:253–259
Bluman LG, Borstelmann NA, Rimer BK, Iglehart JD, Winer EP (2001) Knowledge, satisfaction, and perceived cancer risk among women diagnosed with ductal carcinoma in situ. J Womens Health Gend Based Med 10:589–598
Brewster K, Wileyto EP, Kessler L, Collier A, Weathers B, Stopfer JE, Domchek S, Halbert CH (2007) Sociocultural predictors of breast cancer risk perceptions in African American breast cancer survivors. Cancer Epidemiol Biomarkers Prev 16:244–248
Leitch AM, Dodd GD, Costanza M, Linver M, Pressman P, McGinnis L, Smith RA (1997) American Cancer Society guidelines for the early detection of breast cancer: update 1997. CA Cancer J Clin 47:150–153
Katzman R, Brown T, Fuld P, Peck A, Schechter R, Schimmel H (1983) Validation of a short Orientation-Memory-Concentration Test of cognitive impairment. Am J Psychiatry 140:734–739
Birkett NJ (1988) Computer-aided personal interviewing. A new technique for data collection in epidemiologic surveys. Am J Epidemiol 127:684–690
Sherbourne CD, Stewart AL (1991) The MOS social support survey. Soc Sci Med 32:705–714
Beck AT, Epstein N, Brown G, Steer RA (1988) An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol 56:893–897
Radloff LS (1977) The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas 1:385–401
Schag CA, Ganz PA, Polinsky ML, Fred C, Hirji K, Petersen L (1993) Characteristics of women at risk for psychosocial distress in the year after breast cancer. J Clin Oncol 11:783–793
Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373–383
Katz JN, Chang LC, Sangha O, Fossel AH, Bates DW (1996) Can comorbidity be measured by questionnaire rather than medical record review? Med Care 34:73–84
Andersen MR, Urban N (1999) Involvement in decision-making and breast cancer survivor quality of life. Ann Behav Med 21:201–209
Hedeker D, Mermelstein RJ (2000) Analysis of longitudinal substance use outcomes using ordinal random-effects regression models. Addiction 95(Suppl 3):S381–S394
Liang KY, Zeger SL (1993) Regression analysis for correlated data. Annu Rev Public Health 14:43–68
Huang GH, Palta M, Allen C, LeCaire T, D’Alessio D (2004) Self-rated health among young people with type 1 diabetes in relation to risk factors in a longitudinal study. Am J Epidemiol 159:364–372
Sheu CF (2002) Fitting mixed-effects models for repeated ordinal outcomes with the NLMIXED procedure. Behav Res Methods Instrum Comput 34:151–157
Viani GA, Stefano EJ, Afonso SL, De Fendi LI, Soares FV, Leon PG, Guimaraes FS (2007) Breast-conserving surgery with or without radiotherapy in women with ductal carcinoma in situ: a meta-analysis of randomized trials. Radiat Oncol 2:28
Moran MS, Yang Q, Harris LN, Jones B, Tuck DP, Haffty BG (2008) Long-term outcomes and clinicopathologic differences of African-American versus white patients treated with breast conservation therapy for early-stage breast cancer. Cancer 113:2565–2574
Deshpande AD, Jeffe DB, Gnerlich J, Iqbal AZ, Thummalakunta A, Margenthaler JA (2009) Racial disparities in breast cancer survival: an analysis by age and stage. J Surg Res 153:105–113
Orom H, Kiviniemi MT, Underwood W III, Ross L, Shavers VL (2010) Perceived cancer risk: why is it lower among nonwhites than whites? Cancer Epidemiol Biomarkers Prev 19:746–754
Connor CS, Touijer AK, Krishnan L, Mayo MS (2000) Local recurrence following breast conservation therapy in African-American women with invasive breast cancer. Am J Surg 179:22–26
Schapira MM, McAuliffe TL, Nattinger AB (2000) Underutilization of mammography in older breast cancer survivors. Med Care 38:281–289
Fisher B, Anderson S, Bryant J, Margolese RG, Deutsch M, Fisher ER, Jeong JH, Wolmark N (2002) Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 347:1233–1241
Kornblith AB, Herndon JE II, Zuckerman E, Viscoli CM, Horwitz RI, Cooper MR, Harris L, Tkaczuk KH, Perry MC, Budman D, Norton LC, Holland J (2001) Social support as a buffer to the psychological impact of stressful life events in women with breast cancer. Cancer 91:443–454
Ringdal GI, Ringdal K, Jordhoy MS, Kaasa S (2007) Does social support from family and friends work as a buffer against reactions to stressful life events such as terminal cancer? Palliat Support Care 5:61–69
Carver CS, Meyer B, Antoni MH (2000) Responsiveness to threats and incentives, expectancy of recurrence, and distress and disengagement: moderator effects in women with early stage breast cancer. J Consult Clin Psychol 68:965–975
Lerman C, Schwartz M (1993) Adherence and psychological adjustment among women at high risk for breast cancer. Breast Cancer Res Treat 28:145–155
Bartelink H, Horiot JC, Poortmans P, Struikmans H, Van den Bogaert W, Barillot I, Fourquet A, Borger J, Jager J, Hoogenraad W, Collette L, Pierart M (2001) Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation. N Engl J Med 345:1378–1387
Voogd AC, Nielsen M, Peterse JL, Blichert-Toft M, Bartelink H, Overgaard M, van Tienhoven G, Andersen KW, Sylvester RJ, van Dongen JA (2001) Differences in risk factors for local and distant recurrence after breast-conserving therapy or mastectomy for stage I and II breast cancer: pooled results of two large European randomized trials. J Clin Oncol 19:1688–1697
Brewster AM, Do KA, Thompson PA, Hahn KM, Sahin AA, Cao Y, Stewart MM, Murray JL, Hortobagyi GN, Bondy ML (2007) Relationship between epidemiologic risk factors and breast cancer recurrence. J Clin Oncol 25:4438–4444
Gurmankin Levy A, Shea J, Williams SV, Quistberg A, Armstrong K (2006) Measuring perceptions of breast cancer risk. Cancer Epidemiol Biomarkers Prev 15:1893–1898
Acknowledgments
This study was supported by a grant from the National Cancer Institute and Breast Cancer Stamp Fund (R01CA102777), and by the National Cancer Institute Cancer Center Support Grant (P30 CA91842) to the Alvin J. Siteman Cancer Center at Washington University School of Medicine and Barnes-Jewish Hospital in St. Louis, Missouri. We thank our patient participants, the interviewers, and the Siteman Cancer Center’s Health Behavior and Outreach Core (Ms. Jennifer Tappenden and Dr. Yan Yan) and Biostatistics Core (Dr. Kenneth Schechtman) for data management and statistical services, and Pam Hunborg at Saint Louis University School of Medicine. We also greatly appreciate the many physicians who helped us recruit their patients for this study, including Drs. Barbara Monsees, Jill Dietz, Julie Margenthaler, Virginia Herrmann, Timothy Eberlein, Matthew Ellis, Imran Zoberi, Marie Taylor, Michael Naughton, Antonella Rastelli, Donald Lombardi, Cynthia Ma, Loren Michel, and Rama Suresh at Washington University School of Medicine, and Dr. Eddie Hsueh at Saint Louis University School of Medicine. The Beck Anxiety Inventory ® and BAI ® (copyright 1990, 1993 by Aaron T. Beck) are trademarks of The Psychological Corporation, a Harcourt Assessment Company. The BAI ® was adapted and used by permission of the publisher, The Psychological Corporation. All rights reserved.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Liu, Y., Pérez, M., Schootman, M. et al. A longitudinal study of factors associated with perceived risk of recurrence in women with ductal carcinoma in situ and early-stage invasive breast cancer. Breast Cancer Res Treat 124, 835–844 (2010). https://doi.org/10.1007/s10549-010-0912-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10549-010-0912-1